参考文献/References:
[1] ANDERS H J, SAXENA R, ZHAO Minghui, et al.Lupus nephritis[J]. Nat Rev Dis Primers,2020,6(1):7.
[2] ARINGER M, COSTENBADER K, DAIKH D, et al.2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J].Ann Rheum Dis,2019,78(9):1151-1159.
[3] GANDINO IJ, SCOLNIK M, BERTILLER E, et al.Complement levels and risk of organ involvement in patients with systemic lupus erythematosus[J].Lupus Sci Med,2017 ,4(1):e000209.
[4] 高旋, 杨丰钒, 刘薇, 等. 系统性红斑狼疮患者血清IgG 水平正常及升高与相关免疫学实验室指标的相关分析[J]. 现代检验医学杂志,2021,36(1):68-71.
GAO Xuan, YANG Fengfan, LIU Wei, et al. Correlation analysis between normal and elevated serum IgG levels and related immunological laboratory indexes in patients with systemic lupus erythematosus [J]. Journal of Modern Laboratory Medicine, 2021, 36(1): 68-71.
[5] TROUW L A, PICKERING M C, BLOM A M. The complement system as a potential therapeutic target in rheumatic disease[J].Nat Rev Rheumatol, 2017,13(9):538-547.
[6] WEINSTEIN A, ALEXANDER R V, ZACK D J. A review of complement activation in SLE [J]. Current Rheumatology Reports, 2021, 23(3):16.
[7] YU Haitao, NAGAFUCHI Y, FUJIO K. Clinical and immunological biomarkers for systemic lupus erythematosus[J]. Biomolecules, 2021, 11(7):928.
[8] DIJKSTRA D J, JOELOEMSINGH J V, BAJEMA I M, et al. Complement activation and regulation in rheumatic disease[J]. Semin Immunol, 2019 ,45:101339.
[9] MARTIN M, SMOLAG K I, BJORK A, et al. Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus [J]. Arthritis Res Ther, 2017, 19(1):266.
[10] MERRILL J T, PETRI M A, BUYON J, et al.Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE[J]. Lupus Sci Med, 2018, 5(1):e000263.
[11] TROLDBORG A, JENSEN L, DELEURAN B, et al. The C3dg fragment of complement is superior to conventional C3 as a diagnostic biomarker in systemic lupus erythematosus [J]. Frontiers in Immunology,2018, 9: 581.
[12] KIM A H J, STRAND V, SEN D P, et al. Association of blood concentrations of complement split product iC3b and serum C3 with systemic lupus erythematosus disease activity [J]. Arthritis Rheumatol, 2019 ,71(3):420-430.
[13] DURCAN L , PETRI M . The clinical and serological associations of hypocomplementemia in a longitudinal SLE cohort[J]. Seminars in Arthritis and Rheumatism,2020, 50(5):1081-1086.
[14] 张亚梅, 刘运双, 俸家富. 补体C1q 在诊断狼疮性肾炎中的研究进展[J]. 检验医学与临床, 2020,17(5):705-707.
ZHANG Yamei, LIU Yunshuang, FENG Jiafu.Research progress of complement C1q in the diagnosis of lupus nephritis [J]. Laboratory Medicine and Clinic,2020, 17(5):705-707.
[15] 王艳萍, 邹麟, 郭婷, 等. 抗核糖体P 蛋白, 抗Smith, 抗dsDNA, 抗核小体及抗组蛋白抗体对系统性红斑狼疮的临床价值探讨[J]. 现代免疫学, 2021,41 (5): 353-360,379.
WANG Yanping, ZOU Lin, GUO Ting, et al. The clinical value of anti-ribosomal P protein, anti-Smith, anti-dsDNA, anti-nucleosome and anti-histone antibodies for systemic lupus erythematosus [J].Current Immunology, 2021, 41(5): 353-360, 379.
[16] 刘欢欢, 潘发明, 陈礼文. 抗核小体抗体和抗Sm 抗体鉴别诊断系统性红斑狼疮的Meta 分析[J]. 现代检验医学杂志, 2021, 36(3):1-6, 31.
LIU Huanhuan, PAN Faming, CHEN Liwen. Value of antinucleosome antibody and anti-Sm antibody in the differential diagnosis of systemic lupus erythematosus:A meta-analysis [J]. Journal of Modern Laboratory Medicine, 2021, 36(3):1-6, 31.
[17] SONG Kangkang , LIU Xiaomin , LIU Jiaona , et al. Analysis of clinical and laboratory characteristics and pathology of lupus nephritis-based on 710 renal biopsies in China[J]. Clinical Rheumatology, 2020,39(11): 3353-3363.
[18 中国狼疮肾炎诊断和治疗指南编写组. 中国狼疮肾炎诊断和治疗指南 [J]. 中华医学杂志,2019, 99 (44):3441-3455.
Chinese Lupus Nephritis Diagnosis and Treatment Guidelines Writing Group. Guidelines for the diagnosis and treatment of lupus nephritis in China [J]. National Medical Journal of China, 2019, 99(44):3441-3455.
相似文献/References:
[1]王 森,黄太宏,高 硕,等.系统性红斑狼疮患者乙型肝炎病毒感染的分析研究[J].现代检验医学杂志,2016,31(01):41.[doi:10.3969/j.issn.1671-7414.2016.01.011]
WANG Sen,HUANG Tai-hong,GAO Shuo,et al.Prevalence of Hepatitis B Virus Infection in Systemic
Lupus Erythematosus Patients[J].Journal of Modern Laboratory Medicine,2016,31(05):41.[doi:10.3969/j.issn.1671-7414.2016.01.011]
[2]宋宏岩a,王 红b,李 雷a,等.系统性红斑狼疮患者并发EB病毒或巨细胞病毒感染的回顾性分析[J].现代检验医学杂志,2016,31(01):144.[doi:10.3969/j.issn.1671-7414.2016.01.042]
SONG Hong-yana,WANG Hongb,LI Leia,et al.Retrospective Analysis of Epstein Barr Virus or Cytomegalovirus
Infection in Patients with Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2016,31(05):144.[doi:10.3969/j.issn.1671-7414.2016.01.042]
[3]张允奇a,陆学东b,张银辉b,等.SLE患者血清胱抑素C与血脂的相关性分析[J].现代检验医学杂志,2015,30(04):63.[doi:10.3969/j.issn.1671-7414.2015.04.017]
ZHANG Yun-qia,LU Xue-dongb,ZHANG Yin-huib,et al.Correlation Analysis of Serum Cystatin C and Lipids
Levels in Patients with Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2015,30(05):63.[doi:10.3969/j.issn.1671-7414.2015.04.017]
[4]朱琴芳,丁倩倩,俞钱,等.CD40-1C/T基因多态性与系统性红斑狼疮的相关性研究[J].现代检验医学杂志,2015,30(06):46.[doi:10.3969/j.issn.1671-7414.2015.06.013]
ZHU Qin-fang,DING Qian-qian,YU Qian,et al.Association of CD40 Gene Polymorphism
with the Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2015,30(05):46.[doi:10.3969/j.issn.1671-7414.2015.06.013]
[5]柏明见,冯璟,冯珍如,等.血清清蛋白测定在系统性红斑狼疮活动性评估中的应用价值[J].现代检验医学杂志,2015,30(06):116.[doi:10.3969/j.issn.1671-7414.2015.06.035]
BAI Ming-jian,FENG Jing,FENG Zhen-ru,et al.Application Value of Serum Albumin for Disease Activity of Patient
with Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2015,30(05):116.[doi:10.3969/j.issn.1671-7414.2015.06.035]
[6]丁 海,高 硕,魏红霞,等.系统性红斑狼疮患者外周血SOCS-1基因甲基化的检测及意义[J].现代检验医学杂志,2017,32(01):34.[doi:10.3969/j.issn.1671-7414.2017.01.010]
DING Hai,GAO Shuo,WEI Hong-xia,et al.Detection and the Significance of SOCS-1 Gene Methylation Status
in Peripheral Blood of Systemic Lupus Erythematosus Patients[J].Journal of Modern Laboratory Medicine,2017,32(05):34.[doi:10.3969/j.issn.1671-7414.2017.01.010]
[7]杨依骏,杜建钢,朱琴芳,等.系统性红斑狼疮患者血清IL-10和IL-17水平检测的临床意义[J].现代检验医学杂志,2017,32(03):71.[doi:10.3969/j.issn.1671-7414.2017.03.019]
YANG Yi-jun,DU Jian-gang,ZHU Qin-fang,et al.Clinical Significance of Serum IL-10 and IL-17
in Patients with Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2017,32(05):71.[doi:10.3969/j.issn.1671-7414.2017.03.019]
[8]胡 伟,王 森,黄太宏,等.双阴性调节性T细胞(DN Tregs在系统性红斑狼疮患者外周血中的变化及意义[J].现代检验医学杂志,2017,32(04):25.[doi:10.3969/j.issn.1671-7414.2017.04.007]
HU Wei,WANG Sen,HUANG Tai-hong,et al.Change and Clinical Significance of Peripheral Blood DN Tregs
in Patients with Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2017,32(05):25.[doi:10.3969/j.issn.1671-7414.2017.04.007]
[9]凡瞿明,杜 琴,卢小岚,等.SLE患者外周血单核细胞CD36水平与血脂紊乱的关系[J].现代检验医学杂志,2018,33(03):50.[doi:10.3969/j.issn.1671-7414.2018.03.014]
FAN Qu-ming,DU Qin,LU Xiao-lan,et al.Relationship between CD36 Expression on Peripheral Blood
Monocytes and Dyslipidemia in SLE Patients[J].Journal of Modern Laboratory Medicine,2018,33(05):50.[doi:10.3969/j.issn.1671-7414.2018.03.014]
[10]刘卫霞,庞爱梅,郭绪晓,等.血清抗核抗体荧光核型及抗核抗体谱检测在系统性红斑狼疮诊断中的应用价值分析[J].现代检验医学杂志,2020,35(02):32.[doi:10.3969 / j.issn.1671-7414.2020.02.010]
LIU Wei-xia,PANG Ai-mei,GUO Xu-xiao,et al.Clinical Value of Examination of Serum Antinuclear Antibody(ANA) Fluorescence Pattern and ANA Spectrum on Diagnosis of Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2020,35(05):32.[doi:10.3969 / j.issn.1671-7414.2020.02.010]